Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study.
Détails
ID Serval
serval:BIB_3882E44472F2
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study.
Périodique
Annals of the rheumatic diseases
Collaborateur⸱rice⸱s
European EGPA Study Group
Contributeur⸱rice⸱s
Cameli P., Conti F., Fagni F., Losappio L., Malandrino D., Mazzetti M., Mazzotta R., Moroni L., Palermo A., Ribi C., Schiavon F., Silvestri E., Terrier B., Toniati P.
ISSN
1468-2060 (Electronic)
ISSN-L
0003-4967
Statut éditorial
Publié
Date de publication
12/2022
Peer-reviewed
Oui
Volume
81
Numéro
12
Pages
1769-1772
Langue
anglais
Notes
Publication types: Observational Study ; Multicenter Study ; Journal Article
Publication Status: ppublish
Publication Status: ppublish
Mots-clé
Humans, Rituximab/therapeutic use, Churg-Strauss Syndrome/drug therapy, Granulomatosis with Polyangiitis/drug therapy, Antibodies, Monoclonal, Humanized/therapeutic use, Biological Therapy, Epidemiology, Rituximab, Systemic vasculitis
Pubmed
Web of science
Création de la notice
26/07/2022 12:31
Dernière modification de la notice
16/09/2023 5:54